title: [Study of the effectiveness of cordaron in different types of arrhythmia].
abstract: The employment of Cordaron (Amidaron) in 50 patients with different arrhythmias proved effective in 86% of the cases. Cordaron was most effective in the treatment and prevention of paroxysmal tachycardia, ventricular extrasystole, paroxysmal cardiac fibrillation. It decreases the pulse rate and moderately decreases the arterial pressure without imparing the patients' state. The drug has practically no toxic effect, is well tolerated, convenient for administration and dosage. Cardiovascular insufficiency is no contraindication for its prescription. Carefulness is needed in prescribing Cordaron to patients with atrioventricular conductivity disorders.
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001572:Benzofurans / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
chemical_list: D001572:Benzofurans; D000638:Amiodarone
vernacular_title: Izuchenie effektivnosti kordarona pri razlichnykh aritmiiakh.